Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
iTeos Therapeutics, Inc. (ITOS) had Free Cash Flow per Share of $-0.78 for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-34.61M |
|
-- |
|
-- |
|
$40.02M |
|
$-40.02M |
|
$6.51M |
|
$-33.51M |
|
$-33.51M |
|
$-34.61M |
|
$-34.61M |
|
$-34.61M |
|
$-34.61M |
|
$-40.02M |
|
$-42.16M |
|
43.24M |
|
43.24M |
|
$-0.80 |
|
$-0.80 |
|
| Balance Sheet Financials | |
$537.04M |
|
$5.05M |
|
$121.83M |
|
$658.87M |
|
$38.00M |
|
-- |
|
$57.45M |
|
$95.45M |
|
$563.42M |
|
$563.42M |
|
$563.42M |
|
38.27M |
|
| Cash Flow Statement Financials | |
$-33.76M |
|
$47.69M |
|
$0.03M |
|
$142.43M |
|
$156.85M |
|
$14.42M |
|
$6.63M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
14.13 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-33.87M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-6.14% |
|
-6.14% |
|
-5.25% |
|
-6.14% |
|
$14.72 |
|
|
Free Cash Flow per Share |
$-0.78 |
$-0.78 |
|